nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—CHUK—epithelium—cervical cancer	0.0446	0.102	CbGeAlD
Aminosalicylic Acid—CHUK—renal system—cervical cancer	0.0414	0.0942	CbGeAlD
Aminosalicylic Acid—CHUK—female reproductive system—cervical cancer	0.0331	0.0754	CbGeAlD
Aminosalicylic Acid—CHUK—female gonad—cervical cancer	0.0301	0.0686	CbGeAlD
Aminosalicylic Acid—ALOX5—decidua—cervical cancer	0.0237	0.054	CbGeAlD
Aminosalicylic Acid—MPO—epithelium—cervical cancer	0.0213	0.0484	CbGeAlD
Aminosalicylic Acid—MPO—renal system—cervical cancer	0.0197	0.0449	CbGeAlD
Aminosalicylic Acid—CHUK—lymph node—cervical cancer	0.0194	0.0441	CbGeAlD
Aminosalicylic Acid—ALOX5—female reproductive system—cervical cancer	0.0187	0.0425	CbGeAlD
Aminosalicylic Acid—ALOX5—female gonad—cervical cancer	0.017	0.0387	CbGeAlD
Aminosalicylic Acid—ALOX5—lymph node—cervical cancer	0.0109	0.0249	CbGeAlD
Aminosalicylic Acid—PTGS1—epithelium—cervical cancer	0.0101	0.023	CbGeAlD
Aminosalicylic Acid—PTGS1—uterine cervix—cervical cancer	0.01	0.0228	CbGeAlD
Aminosalicylic Acid—PTGS2—epithelium—cervical cancer	0.00964	0.0219	CbGeAlD
Aminosalicylic Acid—PTGS2—uterine cervix—cervical cancer	0.00956	0.0218	CbGeAlD
Aminosalicylic Acid—PTGS1—renal system—cervical cancer	0.00935	0.0213	CbGeAlD
Aminosalicylic Acid—MPO—lymph node—cervical cancer	0.00924	0.021	CbGeAlD
Aminosalicylic Acid—PTGS1—endometrium—cervical cancer	0.00904	0.0206	CbGeAlD
Aminosalicylic Acid—PTGS2—renal system—cervical cancer	0.00894	0.0204	CbGeAlD
Aminosalicylic Acid—PTGS1—mammalian vulva—cervical cancer	0.00875	0.0199	CbGeAlD
Aminosalicylic Acid—PTGS2—endometrium—cervical cancer	0.00864	0.0197	CbGeAlD
Aminosalicylic Acid—PTGS1—uterus—cervical cancer	0.00833	0.019	CbGeAlD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—CD4—cervical cancer	0.00814	0.0145	CbGpPWpGaD
Aminosalicylic Acid—MPO—Folate Metabolism—MTHFR—cervical cancer	0.00797	0.0142	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—uterus—cervical cancer	0.00797	0.0181	CbGeAlD
Aminosalicylic Acid—CHUK—Downstream TCR signaling—HLA-DQB1—cervical cancer	0.00767	0.0137	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—female reproductive system—cervical cancer	0.00749	0.0171	CbGeAlD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—HES1—cervical cancer	0.00748	0.0133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAIL signaling pathway—CASP8—cervical cancer	0.00744	0.0133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling—HLA-DPB1—cervical cancer	0.00734	0.0131	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—female reproductive system—cervical cancer	0.00716	0.0163	CbGeAlD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—WNT5A—cervical cancer	0.00713	0.0127	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—female gonad—cervical cancer	0.00682	0.0155	CbGeAlD
Aminosalicylic Acid—PTGS1—vagina—cervical cancer	0.00678	0.0154	CbGeAlD
Aminosalicylic Acid—PTGS2—female gonad—cervical cancer	0.00652	0.0148	CbGeAlD
Aminosalicylic Acid—PTGS2—vagina—cervical cancer	0.00648	0.0147	CbGeAlD
Aminosalicylic Acid—MPO—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00633	0.0113	CbGpPWpGaD
Aminosalicylic Acid—MPO—IL23-mediated signaling events—STAT3—cervical cancer	0.0063	0.0112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NOD1/2 Signaling Pathway—CASP8—cervical cancer	0.00626	0.0112	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00598	0.0107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP8—cervical cancer	0.00596	0.0106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD8+ T cells—CD8A—cervical cancer	0.00583	0.0104	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling—HLA-DQB1—cervical cancer	0.00573	0.0102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—FAS (CD95) signaling pathway—CASP8—cervical cancer	0.00568	0.0101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NOD pathway—CASP8—cervical cancer	0.00501	0.00893	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—CASP8—cervical cancer	0.00491	0.00876	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Class I PI3K signaling events mediated by Akt—MTOR—cervical cancer	0.00468	0.00834	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF receptor signaling pathway —CASP8—cervical cancer	0.00457	0.00815	CbGpPWpGaD
Aminosalicylic Acid—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP3—cervical cancer	0.00451	0.00804	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—lymph node—cervical cancer	0.00438	0.00998	CbGeAlD
Aminosalicylic Acid—CHUK—FAS (CD95) signaling pathway—CASP3—cervical cancer	0.0043	0.00767	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP8—cervical cancer	0.00427	0.00762	CbGpPWpGaD
Aminosalicylic Acid—MPO—C-MYB transcription factor network—CD4—cervical cancer	0.00423	0.00754	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—lymph node—cervical cancer	0.00419	0.00954	CbGeAlD
Aminosalicylic Acid—CHUK—Downstream TCR signaling—CD4—cervical cancer	0.00411	0.00734	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00392	0.00698	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—CD8A—cervical cancer	0.00382	0.00681	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—CA9—cervical cancer	0.00376	0.00671	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—CASP3—cervical cancer	0.00372	0.00663	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TWEAK Signaling Pathway—CTNNB1—cervical cancer	0.00358	0.00639	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Hair Follicle Development: Induction (Part 1 of 3)—CTNNB1—cervical cancer	0.00358	0.00639	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—CASP8—cervical cancer	0.00342	0.0061	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PDGF Pathway—STAT3—cervical cancer	0.00331	0.00591	CbGpPWpGaD
Aminosalicylic Acid—CHUK—RANKL/RANK Signaling Pathway—MTOR—cervical cancer	0.00326	0.00581	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cardiac Hypertrophic Response—MTOR—cervical cancer	0.00326	0.00581	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—FGFR3—cervical cancer	0.00324	0.00578	CbGpPWpGaD
Aminosalicylic Acid—CHUK—FoxO family signaling—CTNNB1—cervical cancer	0.00317	0.00565	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—AKAP13—cervical cancer	0.0031	0.00553	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling—CD4—cervical cancer	0.00307	0.00548	CbGpPWpGaD
Aminosalicylic Acid—MPO—Folate Metabolism—TP53—cervical cancer	0.00303	0.0054	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Interleukin-11 Signaling Pathway—STAT3—cervical cancer	0.00301	0.00537	CbGpPWpGaD
Aminosalicylic Acid—CHUK—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—CASP8—cervical cancer	0.00293	0.00523	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—FGFR3—cervical cancer	0.00292	0.0052	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—FGFR3—cervical cancer	0.00285	0.00508	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—cervical cancer	0.00284	0.00506	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—FGFR3—cervical cancer	0.00283	0.00504	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—CASP8—cervical cancer	0.00282	0.00503	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR signaling in naïve CD4+ T cells—CD4—cervical cancer	0.00281	0.00501	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—FGFR3—cervical cancer	0.00276	0.00492	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—CASP8—cervical cancer	0.00262	0.00468	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00259	0.00462	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—CASP3—cervical cancer	0.00259	0.00462	CbGpPWpGaD
Aminosalicylic Acid—CHUK—IL-4 Signaling Pathway—STAT3—cervical cancer	0.00255	0.00456	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—MTOR—cervical cancer	0.00254	0.00453	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—CASP3—cervical cancer	0.0025	0.00446	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytosolic sensors of pathogen-associated DNA—CTNNB1—cervical cancer	0.0025	0.00445	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—CASP8—cervical cancer	0.00247	0.00441	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—CTNNB1—cervical cancer	0.00247	0.0044	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—HES1—cervical cancer	0.00243	0.00434	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—CASP8—cervical cancer	0.00242	0.00431	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—MTOR—cervical cancer	0.00232	0.00414	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.00232	0.00414	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—MTOR—cervical cancer	0.00228	0.00406	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—CASP8—cervical cancer	0.00223	0.00397	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—CD4—cervical cancer	0.00219	0.00391	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—FGFR3—cervical cancer	0.00218	0.00389	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—STAT3—cervical cancer	0.00218	0.00388	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	0.00215	0.00383	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—CASP3—cervical cancer	0.00214	0.00381	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-DPB1—cervical cancer	0.00211	0.00377	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—CASP8—cervical cancer	0.00209	0.00373	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—FGFR3—cervical cancer	0.00209	0.00372	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.00208	0.0037	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—cervical cancer	0.00206	0.00367	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00206	0.00367	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—FGFR3—cervical cancer	0.00205	0.00366	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—MTOR—cervical cancer	0.00205	0.00366	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—MTOR—cervical cancer	0.002	0.00357	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—MTOR—cervical cancer	0.00199	0.00354	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—CASP3—cervical cancer	0.00199	0.00354	CbGpPWpGaD
Aminosalicylic Acid—CHUK—AGE/RAGE pathway—EGFR—cervical cancer	0.00198	0.00353	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Leptin signaling pathway—STAT3—cervical cancer	0.00196	0.0035	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—FGFR3—cervical cancer	0.00196	0.0035	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—EGFR—cervical cancer	0.00195	0.00348	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—FGFR3—cervical cancer	0.00195	0.00348	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—MTOR—cervical cancer	0.00194	0.00346	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—FGFR3—cervical cancer	0.00194	0.00346	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—FGFR3—cervical cancer	0.00193	0.00345	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—cervical cancer	0.00192	0.00342	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—UBE3A—cervical cancer	0.00191	0.0034	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—FGFR3—cervical cancer	0.0019	0.0034	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—CASP8—cervical cancer	0.00189	0.00336	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—CASP8—cervical cancer	0.00186	0.00333	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—FGFR3—cervical cancer	0.00182	0.00324	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—FGFR3—cervical cancer	0.00182	0.00324	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—FGFR3—cervical cancer	0.00182	0.00324	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—FGFR3—cervical cancer	0.0018	0.00321	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—STAT3—cervical cancer	0.00179	0.0032	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—FGFR3—cervical cancer	0.00179	0.00318	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—FGFR3—cervical cancer	0.00178	0.00317	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—CASP8—cervical cancer	0.00177	0.00315	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—FGFR3—cervical cancer	0.00168	0.003	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-DQB1—cervical cancer	0.00165	0.00294	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	0.00164	0.00293	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.00163	0.00291	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—FGFR3—cervical cancer	0.00161	0.00287	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—TP53—cervical cancer	0.0016	0.00286	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Constitutive PI3K/AKT Signaling in Cancer—EGFR—cervical cancer	0.0016	0.00285	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.00156	0.00279	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—MTOR—cervical cancer	0.00153	0.00274	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—MTHFR—cervical cancer	0.00153	0.00272	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—MTOR—cervical cancer	0.00151	0.00269	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CA9—cervical cancer	0.00147	0.00263	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—MTOR—cervical cancer	0.00147	0.00262	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—STAT3—cervical cancer	0.00147	0.00262	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.00146	0.00261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—MTOR—cervical cancer	0.00145	0.00259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—MTOR—cervical cancer	0.00144	0.00258	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI-3K cascade—EGFR—cervical cancer	0.00144	0.00257	CbGpPWpGaD
Aminosalicylic Acid—CHUK—PI3K/AKT activation—EGFR—cervical cancer	0.00141	0.00251	CbGpPWpGaD
Aminosalicylic Acid—CHUK—GAB1 signalosome—EGFR—cervical cancer	0.0014	0.00249	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—CASP3—cervical cancer	0.00139	0.00247	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—MTOR—cervical cancer	0.00138	0.00246	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—MTOR—cervical cancer	0.00137	0.00245	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CD4—cervical cancer	0.00137	0.00245	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TP53—cervical cancer	0.00137	0.00244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—MTOR—cervical cancer	0.00137	0.00244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—cervical cancer	0.00136	0.00243	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—MTOR—cervical cancer	0.00136	0.00242	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—MTOR—cervical cancer	0.00134	0.00239	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—CTNNB1—cervical cancer	0.00134	0.00239	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—CASP3—cervical cancer	0.00134	0.00238	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	0.00129	0.0023	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—MTOR—cervical cancer	0.00128	0.00228	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—MTOR—cervical cancer	0.00128	0.00228	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—MTOR—cervical cancer	0.00128	0.00228	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—MTOR—cervical cancer	0.00127	0.00226	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—MTOR—cervical cancer	0.00126	0.00224	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—MTOR—cervical cancer	0.00125	0.00223	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—FGFR3—cervical cancer	0.00124	0.00221	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—STAT3—cervical cancer	0.00119	0.00211	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—MTOR—cervical cancer	0.00118	0.00211	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—STAT3—cervical cancer	0.00117	0.00208	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—UBE3A—cervical cancer	0.00116	0.00206	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DPB1—cervical cancer	0.00114	0.00203	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	0.00113	0.00202	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.00111	0.00197	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—WNT2—cervical cancer	0.00108	0.00193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—EGFR—cervical cancer	0.00108	0.00192	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.00107	0.0019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—STAT3—cervical cancer	0.00107	0.0019	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—EGFR—cervical cancer	0.00103	0.00184	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—EGFR—cervical cancer	0.00102	0.00182	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—EGFR—cervical cancer	0.00101	0.00181	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—STAT3—cervical cancer	0.000988	0.00176	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TAAR6—cervical cancer	0.000972	0.00173	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—EGFR—cervical cancer	0.000969	0.00173	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—STAT3—cervical cancer	0.000967	0.00172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—EGFR—cervical cancer	0.000964	0.00172	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CASP3—cervical cancer	0.000964	0.00172	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—EGFR—cervical cancer	0.000959	0.00171	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—EGFR—cervical cancer	0.000955	0.0017	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—cervical cancer	0.000941	0.00168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—EGFR—cervical cancer	0.000898	0.0016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—cervical cancer	0.000898	0.0016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—EGFR—cervical cancer	0.000898	0.0016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—EGFR—cervical cancer	0.00089	0.00159	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DQB1—cervical cancer	0.000888	0.00158	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—EGFR—cervical cancer	0.000882	0.00157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—EGFR—cervical cancer	0.000878	0.00157	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.000875	0.00156	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—MTOR—cervical cancer	0.000871	0.00155	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000866	0.00155	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—cervical cancer	0.000856	0.00153	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000845	0.00151	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—EGFR—cervical cancer	0.000831	0.00148	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD8A—cervical cancer	0.000829	0.00148	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—WNT5A—cervical cancer	0.000821	0.00146	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CASP3—cervical cancer	0.000801	0.00143	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000796	0.00142	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—WNT2—cervical cancer	0.000758	0.00135	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—EGFR—cervical cancer	0.000736	0.00131	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.00071	0.00127	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—FGFR3—cervical cancer	0.000706	0.00126	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DPB1—cervical cancer	0.00069	0.00123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—STAT3—cervical cancer	0.000685	0.00122	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—FGFR3—cervical cancer	0.000678	0.00121	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—STAT3—cervical cancer	0.000673	0.0012	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—AKAP13—cervical cancer	0.000666	0.00119	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000656	0.00117	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—WNT2—cervical cancer	0.000642	0.00114	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CA9—cervical cancer	0.000639	0.00114	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000632	0.00113	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—cervical cancer	0.000618	0.0011	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—EGFR—cervical cancer	0.000612	0.00109	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CASP8—cervical cancer	0.000604	0.00108	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—MTHFR—cervical cancer	0.000598	0.00107	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—WNT5A—cervical cancer	0.000575	0.00103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DQB1—cervical cancer	0.000539	0.000961	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CA9—cervical cancer	0.000507	0.000905	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD8A—cervical cancer	0.000503	0.000897	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000501	0.000893	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—MTOR—cervical cancer	0.000497	0.000886	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD4—cervical cancer	0.000496	0.000885	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—WNT5A—cervical cancer	0.000486	0.000867	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—MTOR—cervical cancer	0.000477	0.000851	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD4—cervical cancer	0.000476	0.000849	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HES1—cervical cancer	0.000472	0.000842	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CTNNB1—cervical cancer	0.000441	0.000786	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.00042	0.00075	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTHFR—cervical cancer	0.000415	0.00074	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TERT—cervical cancer	0.000414	0.000738	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—FGFR3—cervical cancer	0.000411	0.000734	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH2—cervical cancer	0.000403	0.00072	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—FGFR3—cervical cancer	0.00038	0.000677	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOTCH1—cervical cancer	0.000357	0.000636	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CASP8—cervical cancer	0.000352	0.000627	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—EGFR—cervical cancer	0.000349	0.000622	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—EGFR—cervical cancer	0.000335	0.000598	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—HES1—cervical cancer	0.000331	0.00059	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TERT—cervical cancer	0.00029	0.000517	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MTOR—cervical cancer	0.000289	0.000516	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—cervical cancer	0.000289	0.000515	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HES1—cervical cancer	0.00028	0.000499	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—MTOR—cervical cancer	0.000267	0.000477	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—cervical cancer	0.000267	0.000476	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—FGFR3—cervical cancer	0.000266	0.000474	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—MTHFR—cervical cancer	0.000259	0.000463	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTNNB1—cervical cancer	0.000257	0.000458	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NOTCH1—cervical cancer	0.00025	0.000445	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTHFR—cervical cancer	0.000246	0.000438	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TERT—cervical cancer	0.000245	0.000437	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CTNNB1—cervical cancer	0.000237	0.000423	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—FGFR3—cervical cancer	0.000225	0.000401	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT3—cervical cancer	0.000224	0.000399	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOTCH1—cervical cancer	0.000211	0.000377	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT3—cervical cancer	0.000207	0.000368	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—MTHFR—cervical cancer	0.000206	0.000367	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—EGFR—cervical cancer	0.000203	0.000363	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—EGFR—cervical cancer	0.000188	0.000335	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—MTOR—cervical cancer	0.000187	0.000334	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CASP3—cervical cancer	0.000172	0.000307	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CTNNB1—cervical cancer	0.000166	0.000296	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—MTOR—cervical cancer	0.000158	0.000282	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—cervical cancer	0.000158	0.000282	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT3—cervical cancer	0.000145	0.000258	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CTNNB1—cervical cancer	0.00014	0.00025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—EGFR—cervical cancer	0.000131	0.000234	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT3—cervical cancer	0.000122	0.000218	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—EGFR—cervical cancer	0.000111	0.000198	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—cervical cancer	0.00011	0.000197	CbGpPWpGaD
